Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

scientific article published on 14 August 2015

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1004219008
P356DOI10.1186/S12885-015-1584-3
P932PMC publication ID4535277
P698PubMed publication ID26272451
P5875ResearchGate publication ID281056492

P50authorMichael P. LuxQ37372079
Alexander HeinQ52723502
Peter A. FaschingQ64005064
Matthias W. BeckmannQ72940290
P2093author name stringClaudia Rauh
Michael G Schrauder
Sebastian M Jud
Falk C Thiel
Thomas Hildebrandt
Sandra-Maria Knetzger
P2860cites workAudio-visual presentation of information for informed consent for participation in clinical trialsQ24242462
Patient recruitment: the costly and growing bottleneck in drug developmentQ34508466
Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysisQ35211304
Volunteers or victims: patients' views of randomised cancer clinical trialsQ36081054
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapyQ36616439
A comparison of patient knowledge of clinical trials and trialist prioritiesQ36897782
Breast Cancer Risk - From Genetics to Molecular Understanding of PathogenesisQ37660589
Organizational barriers to physician participation in cancer clinical trials.Q38456986
Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working GroupQ38570888
Attitudes toward clinical trials among patients and the publicQ38578716
Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials.Q39263130
???Q56786696
Knowledge and understanding among cancer patients consenting to participate in clinical trialsQ40042701
Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general communityQ40842478
Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinicQ41442232
Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure.Q44608892
Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trialQ47606092
Clinical trials and healthy volunteersQ48367211
Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.Q50954453
The impact of disease severity on the informed consent process in clinical research.Q52049125
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.Q53300225
Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate.Q54117864
Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills trainingQ56786171
Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their DecisionQ58854485
Strategic physician communication and oncology clinical trialsQ73042298
Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational bookletQ74660681
Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialistsQ78112943
P407language of work or nameEnglishQ1860
P304page(s)587
P577publication date2015-08-14
P1433published inBMC CancerQ326300
P1476titleKnowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases
P478volume15

Reverse relations

cites work (P2860)
Q58699631Cancer Health Literacy and Willingness to Participate in Cancer Research and Donate Bio-Specimens
Q45887603Combined cell-gene therapy for lung cancer: rationale, challenges and prospects.
Q38783324Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents
Q38939419Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done?
Q38772165The development of high-content screening (HCS) technology and its importance to drug discovery
Q88432061The effects of an educational program for non-physician health care providers regarding fertility preservation

Search more.